Abstract:<p>Although polymer-gadolinium conjugates-based contrast agents (CAs) have shown great promise in safe and efficient magnetic resonance imaging (MRI), very few studies on the use of self-assembled polymers to prepare CAs have been reported. The effect of the self-assembled architectural structures of CAs on their MRI performance remains unclear. Herein, two block amphiphilic polymer-gadolinium conjugates (Linear Agent and Cross-Linked Agent3) were designed and fabricated via an approach of two-step reversible addition-fragmentation chain transfer (RAFT) polymerization and cross-linking. These conjugates self-assembled into nanoscale CAs with a spherical or worm-like morphology. These CAs had low toxicity and great hemocompatibility. Both of them displayed an evident increase in the longitudinal relaxivity and the blood circulation time over small molecular CAs (i.e., Gd-DTPA). Linear Agent exhibited superior MRI signal enhancement to Cross-Linked Agent3 in both subcutaneous and orthotopic breast tumor sites. Cross-Linked Agent3 was easily uptaken by tumor cells, but its tumor-specific responsive degradation contributed to a decrease in its MRI efficiency. In the major organs, two agents were able to generate clear and long-lasting images. Moreover, their long residence time in the blood endowed them as magnetic resonance angiography (MRA) agents. A large number of blood vessels, including liver vessels and kidney vessels, could be clearly observed after injection of both CAs, and the contrast-enhanced MR signals in these vessels lasted for over 4 h. Cross-Linked Agent3 excelled over Linear Agent in displaying the terminal of branch blood vessels in the liver and kidney. Overall, the strategy to prepare self-assembled CAs with tunable morphologies would allow a better understanding of the structure–function relationship of these CAs and provide insights into novel designs of polymer-gadolinium conjugates.</p>

Prolonged in vivo circulation time by zwitterionic modification of magnetite nanoparticles for blood pool contrast agents.

Low Toxicity and Long Circulation Time of Polyampholyte-Coated Magnetic Nanoparticles for Blood Pool Contrast Agents.

Microwave-Assisted Synthesis of Magnetite Nanoparticles for Mr Blood Pool Contrast Agents

Polyphosphoric acid capping radioactive/upconverting NaLuF4: Yb,Tm,153Sm nanoparticles for blood pool imaging invivo

Delayed hepatic uptake of multi-phosphonic acid poly(ethylene glycol) coated iron oxide measured by real-time Magnetic Resonance Imaging

Synthesis of well-dispersed aqueous-phase magnetite nanoparticles and their metabolism as an MRI contrast agent for the reticuloendothelial system

A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox‐sensitive biodegradable macromolecular MRI contrast agent

High-performance Single Compound Multifunctional Agents: Rapid Ligand-Exchange Strategy, Enhanced Dual-modality MR Contrast and Magnetic Hyperthermia

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Antifouling Manganese Oxide Nanoparticles: Synthesis, Characterization, and Applications for Enhanced MR Imaging of Tumors

Synthesis, self-assembly, and characterization of PEG-coated iron oxide nanoparticles as potential MRI contrast agent.

Ultrasmall catechol-PEG-anchored ferrite nanoparticles for high-sensitive magnetic resonance angiography

Amphiphilic block polymer-gadolinium conjugates: Design, synthesis and application as efficient and safe nanoscale magnetic resonance imaging contrast agents

2, 3-Dimercaptosuccinic Acid-Modified Iron Oxide Clusters for Magnetic Resonance Imaging

A T1/T2 dual functional iron oxide MRI contrast agent with super stability and low hypersensitivity benefited by ultrahigh carboxyl group density

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.

High relaxivity Gd3+-based organic nanoparticles for efficient magnetic resonance angiography

Octapod iron oxide nanoparticles as high-performance T 2 contrast agents for magnetic resonance imaging

Amorphous Albumin Gadolinium-Based Nanoparticles for Ultrahigh-Resolution Magnetic Resonance Angiography

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast<i>T</i><sub>1</sub>- and<i>T</i><sub>2</sub>-weighted magnetic resonance imaging